ARV-Based HIV Prevention Technologies: Developing the Capacity and Tools to Deliver New Prevention Products
THE ISSUE IN BRIEF
Supported by the Bill & Melinda Gates Foundation, this project examines the delivery and implementation of the use of antiretroviral drugs as a pre-exposure prophylaxis (PrEP) in comprehensive HIV prevention programs. The O’Neill Institute is part of a larger global effort with several partners, which include Imperial College London, the London School of Hygiene and Tropical Medicine, WHO, UNAIDS, Results for Development Institute, and AVAC.
Thematic Area: Infectious Diseases
Status: Completed
Project Personnel
- Alexandra Jones
- Alison Woodworth
- Aliza Y. Glasner
- Jacqueline S. Huh
- Lawrence Gostin
- Mark Dybul
- Susan C. Kim
RELATED LINKS
- Planning for PrEP
- Global Preparation for Pre-Exposure Prophylaxis to Prevent the Transmission of HIV
- AIDS Vaccine Advocacy Coalition
- Bill & Melinda Gates Foundation
- Institute for Global Health, Imperial College London
- London School of Hygiene and Tropical Medicine
- UNAIDS
- WHO
- Results for Development Institute